COLL Stock Summary and Trading Ideas (Collegium Pharmaceutical | NASDAQ:COLL)

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Collegium Pharmaceutical trades on the NASDAQ stock market under the symbol COLL.

As of April 19, 2024, COLL stock price climbed to $34.84 with 312,906 million shares trading.

COLL has a beta of 0.66, meaning it tends to be less sensitive to market movements. COLL has a correlation of 0.08 to the broad based SPY ETF.

COLL has a market cap of $1.11 billion. This is considered a Small Cap stock.

Last quarter Collegium Pharmaceutical reported $150 million in Revenue and $1.58 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.92.

In the last 3 years, COLL stock traded as high as $40.95 and as low as $14.04.

The top ETF exchange traded funds that COLL belongs to (by Net Assets): CALF, IJR, VTI, IWM, VXF.

COLL has outperformed the market in the last year with a return of +52.3%, while the SPY ETF gained +21.2%. In the last 3 month period, COLL beat the market returning +5.6%, while SPY returned +3.0%. However, in the most recent 2 weeks COLL has underperformed the stock market by returning -12.9%, while SPY returned -4.5%.

COLL support price is $33.95 and resistance is $35.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COLL stock will trade within this expected range on the day.